Stocktoria
Dianthus Therapeutics, Inc. /DE/ DNTH
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Dianthus Therapeutics, Inc. /DE/ institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 1,648,983 | $138.4M | 3.82% |
| Point72 Asset Management, L.P. | 643,599 | $54.0M | 1.49% |
| BlackRock Finance, Inc. | 1,603,547 | $41.5M | 3.71% |
| MILLENNIUM MANAGEMENT LLC | 261,962 | $22.0M | 0.61% |
| D. E. Shaw & Co., Inc. | 149,609 | $12.6M | 0.35% |
| AQR CAPITAL MANAGEMENT LLC | 4,118 | $345,582 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.